Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

3 ArticlesPEL

1 / 1

FDA’s New Rules Propels Generic and Biosimilar Approvals

Effective January 9th 2017, the US Food and Drug Administration (FDA) has announced an amendment to the final rule ((the rule governs the manner in which FDA ...

Nov 10, 2016

Original-Abbreviated-New-Drug-Application-ANDA-Approvals-10-November-2016.png

Piramal Enterprises Buys US Based API Developer Ash Stevens for 354 Crs.

Piramal Enterprises US subsidiary has sealed the deal to acquire US based active pharmaceutical ingredient manufacturing (API) firm Ash Stevens Inc for $52.95 ...

Aug 18, 2016

Ash-Steven-logo.png

Piramal Healthcare Buys Promoter Cos, Gets into Financials, Merges Part of PIRLIFE

Piramal Healthcare has been in the news recently for having sold their formulations division to Abbott, for about 17,000 crores. With the cash, they bought ...

May 09, 2011

Join Capitalmind Premium

Starts at ₹1,999/mo

Get access to our equity, fixed income, macro and personal finance research, model equity and fixed-income portfolios, exclusive apps, tutorials, and member community.